The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ASTERIAS BIOTHERAPEUTICS INC COM SER A 04624N107 17,019 3,699,848 SH   DFND 1 3,699,848 0 0
ASTERIAS BIOTHERAPEUTICS INC *W EXP 02/15/201 04624N115 179 328,205 SH   DFND 1 328,205 0 0
BIOTIME INC COM 09066L105 89,878 24,897,032 SH   DFND 1 24,897,032 0 0
CYNOSURE INC CL A 232577205 61,051 1,338,827 SH   DFND 1 1,338,827 0 0
ISHARES TR RUSSELL 2000 ETF 464287655 56,637 420,000 SH   DFND 1 420,000 0 0
ONCOCYTE CORPORATION COM 68235C107 18,553 2,631,680 SH   DFND 1 2,631,680 0 0
MONSTER BEVERAGE CORP NEW COM 61174X109 212,717 4,797,408 SH   DFND 1 4,797,408 0 0
MALLINCKRODT PUB LTD CO SHS G5785G107 16,063 322,411 SH   DFND 1 322,411 0 0
STAAR SURGICAL CO COM PAR $0.01 852312305 117,779 10,855,179 SH   DFND 1 10,855,179 0 0